臨床眼科74巻3号

2020年03月発行

連載 今月の話題

Pachychoroid neovasculopathy—新たな疾患概念とアジアにおける重要性

著者： 玉城環¹² 古泉英貴²

所属機関： ¹豊見城中央病院眼科 ²琉球大学大学院医学研究科医学専攻眼科学講座

ページ範囲：P.252 - P.257

　近年，pachychoroidという新しい概念の登場により，AMD診療において，新たな診断基準の確立や治療方針を見直す動きが出始めている。本稿ではpachychoroid neovasculopathyについて，現時点での解釈について概説する。

参考文献

1）Cheung CMG, Lee WK, Koizumi H et al：Pachychoroid disease. Eye（Lond） 33：14-33, 2019

2）Warrow DJ, Hoang QV, Freund KB：Pachychoroid pigment epitheliopathy. Retina 33：1659-1672, 2013

3）Pang CE, Freund KB：Pachychoroid neovasculopathy. Retina 35：1-9, 2015

4）Dansingani KK, Balaratnasingam C, Klufas MA et al：Optical coherence tomography angiography of shallow irregular pigment epithelial detachments In pachychoroid spectrum disease. Am J Ophthalmol 160：1243-1254, 2015

5）Miyake M, Ooto S, Yamashiro K et al：Pachychoroid neovasculopathy and age-related macular degeneration. Sci Rep 5：16204, 2015

6）Hata M, Yamashiro K, Ooto S et al：Intraocular vascular endothelial growth factor levels in pachychoroid neovasculopathy and neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 58：292-298, 2017

7）Terao N, Koizumi H, Kojima K et al：Distinct aqueous humour cytokine profiles of patients with pachychoroid neovasculopathy and neovascular age-related macular degeneration. Sci Rep 8：10520, 2018

8）Matsumoto H, Hiroe T, Morimoto M et al：Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and type 1 neovascular age-related macular degeneration. Jpn J Ophthalmol 62：144-150, 2018

9）Jung BJ, Kim JY, Lee JH et al：Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy. Sci Rep 9：2055, 2019

10）Maruko I, Iida T, Sugano Y et al：Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 151：594-603, 2011

11）Koizumi H, Kano M, Yamamoto A et al：Subfoveal choroidal thickness during aflibercept therapy for neovascular age-related macular degeneration：twelve-month results. Ophthalmology 123：617-624, 2016

12）Sakurada Y, Sugiyama A, Tanabe N et al：Choroidal thickness as a prognostic factor of photodynamic therapy with aflibercept or ranibizumab for polypoidal choroidal vasculopathy. Retina 37：1866-1872, 2017

13）Chan WM, Lam DS, Lai TY et al：Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin：a novel treatment at the primary disease level. Br J Ophthalmol 87：1453-1458, 2003

14）Lee JH, Lee WK：One-year results of adjunctive photodynamic therapy for type 1 neovascularization associated with thickened choroid. Retina 36：889-895, 2016